Improving genetic risk modeling of dementia from real-world data in underrepresented populations

被引:0
|
作者
Fu, Mingzhou [1 ,2 ]
Valiente-Banuet, Leopoldo [1 ]
Wadhwa, Satpal S. [1 ]
Pasaniuc, Bogdan [3 ]
Vossel, Keith [1 ]
Chang, Timothy S. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Bioinformat, Med Informat Home Area, Los Angeles, CA 90024 USA
[3] David Geffen Sch Med UCLA, Dept Computat Med, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
ALZHEIMERS-DISEASE; DIAGNOSIS; VARIANTS; SCORE; IDENTIFICATION; METAANALYSIS; ASSOCIATION; ANCESTRY; PROGRESS; LOCI;
D O I
10.1038/s42003-024-06742-0
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genetic risk modeling for dementia offers significant benefits, but studies based on real-world data, particularly for underrepresented populations, are limited. We employ an Elastic Net model for dementia risk prediction using single-nucleotide polymorphisms prioritized by functional genomic data from multiple neurodegenerative disease genome-wide association studies. We compare this model with APOE and polygenic risk score models across genetic ancestry groups (Hispanic Latino American sample: 610 patients with 126 cases; African American sample: 440 patients with 84 cases; East Asian American sample: 673 patients with 75 cases), using electronic health records from UCLA Health for discovery and the All of Us cohort for validation. Our model significantly outperforms other models across multiple ancestries, improving the area-under-precision-recall curve by 31-84% (Wilcoxon signed-rank test p-value <0.05) and the area-under-the-receiver-operating characteristic by 11-17% (DeLong test p-value <0.05) compared to the APOE and the polygenic risk score models. We identify shared and ancestry-specific risk genes and biological pathways, reinforcing and adding to existing knowledge. Our study highlights the benefits of integrating functional mapping, multiple neurodegenerative diseases, and machine learning for genetic risk models in diverse populations. Our findings hold potential for refining precision medicine strategies in dementia diagnosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [42] Improving pragmatic clinical trial design using real-world data
    Shortreed, Susan M.
    Rutter, Carolyn M.
    Cook, Andrea J.
    Simon, Gregory E.
    CLINICAL TRIALS, 2019, 16 (03) : 273 - 282
  • [43] Traumatic brain injury and risk of dementia: A meta-analysis of cohort studies using real-world data
    Hussain, M. S.
    Rahman, S. O.
    Najmi, A. K.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 122 - 122
  • [44] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] Inaccurate Real-World Data Does Not Provide Real-World Answers
    Buffet, Gabriela
    Mendoza-Sassi, Raul
    Fysekidis, Marinos
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (05) : E596 - E598
  • [46] For insights into the real world, consider real-world data
    Raoof, Sana
    Kurzrock, Razelle
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (673)
  • [47] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [49] Higher Dementia Risk in People With Gastroesophageal Reflux Disease: A Real-World Evidence
    Gau, Shuo-Yan
    Lai, Jung-Nien
    Yip, Hei-Tung
    Wu, Meng-Che
    Wei, James Cheng-Chung
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [50] Real-World or Controlled Clinical Trial Data in Real-World Practice
    Wu, Ting-Hui
    Yang, James Chih-Hsin
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 470 - 472